Track Zealand Pharma A/S.'s total liabilities ($1.1B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2022), ZEAL shows a total liabilities of $1.1B. Scroll down for historical charts and peer comparison views.
Tracking ZEAL's total liabilities over time shows whether Zealand Pharma A/S. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Zealand Pharma A/S.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.1B) with ownership activity and broader fundamentals.
Zealand Pharma A/S.'s total liabilities is $1.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.